Valdés-Sotomayor Jorge, Cirugeda Antonio, Bajo María-Auxiliadora, del Peso Gloria, Escudero Elena, Sánchez-Tomero José A, Selgas Rafael
Department of Nephrology, Hospital Universitario de la Princesa, Hospital Universitario La Paz, Instituto Reina Sofía de Investigación Nefrológica, Madrid, Spain.
Perit Dial Int. 2003 Sep-Oct;23(5):450-5.
Despite improvements in peritoneal dialysis (PD) technique, peritonitis continues to be one of the most frequent complications of PD. Nonresolving peritonitis remains a risk for severe anatomical peritoneal changes that may limit the viability of the membrane for dialysis purposes. We have observed remarkably poor outcome of peritonitis caused by Escherichia coli in the past 6 years. With its very low response rate to broad-spectrum antibiotics, the increased severity of E. coli peritonitis deteriorates peritoneal function and affects patient outcome.
Retrospective study.
Two large PD units in two university hospitals.
The total number of patients reviewed was 456. The records of 49 E. coli peritonitis episodes were studied.The observation period started in 1980 and ended in March 2001. Sixteen males and 19 females were included. Severity was defined in terms of days of peritoneal inflammation, lack of response to a potentially useful antibiotic, requirement for catheter removal, and/or laparotomy. Study cases (study group) were those episodes appearing after 1996 (when the first severe cases appeared) and historic controls were episodes occurring before 1996.
In the study group, 18 peritonitis episodes developed in 15 patients. In the control group, 31 peritonitis episodes developed in 20 patients. There were no significant differences in clinical presentation; however, the outcome was significantly poorer for the later period. A severe outcome occurred in 50% of study versus 10% of control patients. In fact, 68% of the episodes registered before 1996 were cured in 3 days or less. Concurring with this trend, the numbers of surgical interventions and catheter removals were also higher in the study group. Strikingly, E. coli did not show changes in in vitro susceptibility testing to antibiotics, although the in vivo response was much worse.
We describe a change in the virulence of E. coli peritonitis episodes over the past 5 years leading to a high percentage of treatment failure, which does not depend on antibiotic sensitivity and seems to be dependent on changes in host response mechanisms.
尽管腹膜透析(PD)技术有所改进,但腹膜炎仍然是PD最常见的并发症之一。持续性腹膜炎仍然是严重腹膜解剖结构改变的风险因素,这可能会限制腹膜用于透析的功能。在过去6年中,我们观察到由大肠杆菌引起的腹膜炎预后非常差。由于其对广谱抗生素的反应率极低,大肠杆菌性腹膜炎的严重程度增加,会使腹膜功能恶化并影响患者预后。
回顾性研究。
两所大学医院的两个大型PD治疗中心。
共审查了456例患者。研究了49例大肠杆菌性腹膜炎发作的记录。观察期从1980年开始,至2001年3月结束。其中包括16名男性和19名女性。根据腹膜炎症天数、对可能有效的抗生素无反应、是否需要拔除导管和/或进行剖腹手术来定义严重程度。研究病例(研究组)为1996年以后出现的发作(首例严重病例出现之时),历史对照为1996年以前发生的发作。
研究组中,15例患者发生了18次腹膜炎发作。对照组中,20例患者发生了31次腹膜炎发作。临床表现无显著差异;然而,后期的预后明显较差。研究组50%的患者出现严重预后,而对照组为10%。事实上,1996年以前记录的发作中,68%在3天或更短时间内治愈。与这一趋势一致,研究组的手术干预和导管拔除次数也更高。引人注目的是,尽管体内反应差得多,但大肠杆菌的体外抗生素敏感性测试未显示变化。
我们描述了过去5年中大肠杆菌性腹膜炎发作毒力的变化,导致治疗失败率很高,这并不取决于抗生素敏感性,似乎取决于宿主反应机制的变化。